CYP2J2 overexpression or addition of exogenous EETs protected human carcinoma cells from apoptosis by upregulating the antiapoptotic proteins, Bcl-2 and Bcl-xL, and by downregulating the proapoptotic protein, Bax [10]. The gene discussed is CYP2J2; the disease is carcinoma.